University of Texas Southwestern Medical Center-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Texas Southwestern Medical Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013272
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:129
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Texas Southwestern Medical Center (UTSMC), a subsidiary of University of Texas System is an educational center that offers medical research and education programs. The center offers degree programs, which include master’s degree in business administration, public health, medical scientist training program and bachelor of arts in biology. It offers training programs in various fields. The center carries out research activities in the areas of oncology, diabetes, obesity, cardiology, metabolism and nutrition, trauma and others. It operates through its academic medical centers, patient care providers and research institutions. UTSMC is headquartered in Dallas, Texas, the US.

University of Texas Southwestern Medical Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 6
University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
University of Texas Southwestern Medical Center, Medical Devices Deals, 2011 to YTD 2017 11
University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deal Details 14
Partnerships 14
University of Texas Southwestern Medical Center Extends Licensing Agreement With DioGenix For MSPrecise Sequencing Assay 14
Peloton Therapeutics Enters into Agreement with University of Texas Southwestern Medical Center 15
Immune-Onc Therapeutics Enters into Research Agreement with University of Texas Health Science Center at Houston and University of Texas Southwestern Medical Center 16
CureMeta Enters into Research Agreement with University of Texas Southwestern Medical Center 17
SignaBlok Enters into Agreement with University of Texas Southwestern Medical Center 18
Affitech Enters Into Research Agreement With UT Southwestern For AT001/r84 19
Licensing Agreements 20
Pieces Tech Enters into Licensing Agreement with University of Texas Southwestern Medical Center 20
Immune-Onc Therapeutics Enters into Licensing Agreement with University of Texas Health Science Center at Houston and University of Texas Southwestern Medical Center 21
arGEN-X Enters into Licensing Agreement with University of Texas Southwestern Medical Center 22
Lonestar Heart Acquires Rights from University of Texas Southwestern Medical 23
arGEN-X Amends its Licensing Agreement with University of Texas Southwestern Medical Center for NHance Technology 24
University Of Illinois And University Of Texas Enter Into Licensing Agreement With StemPar Sciences For Anti-Cancer Compounds 25
LoneStar Heart Enters Into Licensing Agreement With UT Southwestern Medical Center For Isoxazoles 26
University of Texas Southwestern Medical Center – Key Competitors 27
University of Texas Southwestern Medical Center – Key Employees 28
University of Texas Southwestern Medical Center – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Government and Public Interest 31
Nov 22, 2017: University of Texas Southwestern Medical Center: More not necessarily better with heart valve operations 31
Nov 13, 2017: O’Donnell Brain Institute joins global effort to map human cells 32
Nov 07, 2017: Hamon Charitable Foundation $10M gift fuels Alzheimer’s research 33
Nov 01, 2017: Study: Autism Treatments May Restore Brain Connections 34
Oct 03, 2017: Genetic Targets to Chemo-Resistant Breast Cancer Identified 35
Sep 19, 2017: CPRIT awards $34M to UTSW for cancer research recruitment 36
Aug 24, 2017: CRI scientists develop an innovative system to characterize regulatory DNA sequences responsible for human diseases 38
Aug 21, 2017: CRI scientists discover vitamin C regulates stem cell function and suppresses leukemia development 39
Aug 08, 2017: First-in-class drug holds promise for therapy-resistant breast cancer 41
Jul 27, 2017: UT Southwestern researchers find link between backup immune defense, mutation seen in Crohn’s disease 42
Jul 21, 2017: CRI Scientists Increase our Understanding of the Genetic Basis of Neuropsychiatric Disorders 44
Jul 07, 2017: Researchers report chemical reaction with potential to speed drug development 45
Jun 13, 2017: Researchers identify best treatment for iron deficiency anemia in children 46
Jun 12, 2017: Study: New approach to destroying deadly brain tumors 47
Jun 12, 2017: Beat AML clinical trial for leukemia is launched 49
May 23, 2017: Using a genetic signature to overcome chemotherapy-resistant lung cancer 51
May 22, 2017: DNA vaccine protects against toxic proteins linked to Alzheimer’s 53
May 09, 2017: Research elucidates hormone ghrelin’s role in blood glucose regulation, a finding with promising implications for diabetes treatment 55
May 01, 2017: Stereotactic radiation highly effective for kidney cancer 56
Apr 12, 2017: Gene-editing alternative corrects Duchenne muscular dystrophy 57
Feb 06, 2017: Researchers identify ion channel necessary for hormone and anti-obesity drug to suppress eating 58
Jan 24, 2017: Researchers discover BRCA1 gene is key for blood forming stem cells 59
Jan 24, 2017: Researchers discover potential new target for treating glioblastoma 60
Jan 11, 2017: Scientists identify protein central to immune response against tuberculosis bacteria 62
Dec 20, 2016: Illuminating cancer: Researchers invent a pH threshold sensor to improve cancer surgery 63
Dec 13, 2016: CRI scientists discover new bone-forming growth factor that reverses osteoporosis in mice 65
Oct 26, 2016: Regenerative Medicine Scientists Get the Upperhand in Biological Pathway that Leads to Heart Formation 66
Oct 20, 2016: New research verifies TASINs as viable target for colon cancer therapies 67
Oct 11, 2016: Researchers amplify regeneration of spinal nerve cells 68
Oct 07, 2016: Researchers find novel function for old protein in work that could lead to new ways to protect brain from stroke damage 70
Sep 26, 2016: Gene Regulation In Brain May Explain Repetitive Behaviors In Rett Syndrome Patients 71
Sep 21, 2016: Neutrophils are key to harnessing anti-tumor immune response from radiation therapy, study finds 73
Sep 16, 2016: Scientists enhance ability of antibiotics to defeat resistant types of bacteria using molecules called PPMOs 75
Aug 24, 2016: Research identifies protein that promotes the breakdown of fat, potentially leading to new diabetes treatments 77
Aug 24, 2016: CPRIT awards $9.6 million for UTSW projects in cancer treatments, screening, and genetics research 78
Aug 22, 2016: Blocking Release Of The Hormone Ghrelin May Mediate Low Blood Sugar Effect In Children Taking Beta Blockers, UT Southwestern Study Shows 80
Aug 02, 2016: Study Finds Innate Immunity Connection To Rare, Fatal Childhood Disease, And Possibly TB 81
Aug 01, 2016: UT Southwestern Targets Rising Rates Of Kidney Cancer With Four-Pronged Attack Funded By National Cancer Institute 83
Jul 28, 2016: Scientists discover new therapeutic target for lung cancer driven by KRAS 84
Jul 21, 2016: New therapeutic targets for small cell lung cancer identified 85
Jun 29, 2016: New method detects telomere length for research into cancer, aging 86
Jun 09, 2016: New mode of action for streptomycin holds promise of treating drug-resistant infections 87
Jun 03, 2016: Study shows Zika virus directly infects brain cells and evades immune system detection 88
May 17, 2016: Cancer Prevention and Research Institute of Texas Marks Progress at the Halfway Point of its Funding 89
May 02, 2016: Team identifies new function of genes linked to Fanconi anemia and certain types of cancer 91
Apr 21, 2016: Research In Liver Cancer, Tissue Regeneration At Children’s Research Institute At UT Southwestern Garners Stand Up To Cancer Grant 93
Apr 07, 2016: Common prostate cancer treatments suppress immune response and may promote relapse 94
Apr 06, 2016: CRI scientists find novel metabolic twist that drives cancer survival 96
Apr 05, 2016: Resuscitation drugs can be beneficial to restoring heart rhythm after cardiac arrest 98
Mar 28, 2016: Researchers Find Mutation That Causes Rare Disease And Confirm A Role For Nucleic Acids In Immune Function 99
Mar 25, 2016: CRI researchers link absence of protein to liver tissue regeneration 101
Mar 18, 2016: Lupus study shows precision medicine’s potential to define the genetics of autoimmune disease 103
Mar 17, 2016: Researchers find new cytoplasmic role for proteins linked to neurological diseases, cancers 105
Mar 11, 2016: UTSW researchers find newly identified immunity pathway protects mammals from virus-cause 106
Feb 26, 2016: Light reflectance technique improves ability to remove prostate cancer during surgery 107
Feb 08, 2016: Nanoparticle therapy that uses LDL and fish oil kills liver cancer cells 108
Feb 04, 2016: CRI develops approach for identifying processes that fuel tumor growth in lung cancer patients 110
Feb 04, 2016: Children’s Research Institute develops innovative approach for identifying processes that fuel tumor growth in lung cancer patients 111
Feb 01, 2016: Drug that could aid in vaccine development activates innate immune system in a novel way 112
Jan 26, 2016: HIV protein manipulates hundreds of human genes to advance progression into AIDS, study shows 113
Jan 22, 2016: Tumor-suppressing gene works by restraining mobile genetic elements that can lead to genomic instability 114
Jan 21, 2016: UT Southwestern study shows how certain drugs alter metabolism of pancreatic cancer cells 115
Jan 15, 2016: UT Southwestern researchers identify process that causes chronic neonatal lung disease 116
Jan 14, 2016: Researchers find a small protein that plays a big role in heart muscle contraction 117
Product News 118
Dec 06, 2016: Researchers find new biomarker for brain cancer prognosis 118
Sep 14, 2016: Drug-loaded synthetic nanoparticles can distinguish lung cancer cells from healthy cells 119
08/30/2017: UT Health San Antonio researchers developing drug for recurring ER-positive breast cancer 121
Apr 24, 2017: Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types 122
Feb 06, 2017: UTSW identifies ion channel necessary for hormone and anti-obesity drug to suppress eating 124
02/03/2017: Cancer drug could promote regeneration of heart tissue 125
Jan 25, 2016: Scientists Synthesize Nanoparticles That Can Deliver Tumor Suppressors To Damaged Livers 126
Jan 03, 2017: Researchers uncover mechanism for cancer-killing properties of pepper plant 127
Other Significant Developments 128
Mar 02, 2016: UTSW collaborates to develop device to combat memory loss from brain injury, epilepsy, Alzheimer’s disease 128
Appendix 129
Methodology 129
About GlobalData 129
Contact Us 129
Disclaimer 129

List of Tables
University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Key Facts 2
University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
University of Texas Southwestern Medical Center, Deals By Therapy Area, 2011 to YTD 2017 10
University of Texas Southwestern Medical Center, Medical Devices Deals, 2011 to YTD 2017 11
University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
University of Texas Southwestern Medical Center Extends Licensing Agreement With DioGenix For MSPrecise Sequencing Assay 14
Peloton Therapeutics Enters into Agreement with University of Texas Southwestern Medical Center 15
Immune-Onc Therapeutics Enters into Research Agreement with University of Texas Health Science Center at Houston and University of Texas Southwestern Medical Center 16
CureMeta Enters into Research Agreement with University of Texas Southwestern Medical Center 17
SignaBlok Enters into Agreement with University of Texas Southwestern Medical Center 18
Affitech Enters Into Research Agreement With UT Southwestern For AT001/r84 19
Pieces Tech Enters into Licensing Agreement with University of Texas Southwestern Medical Center 20
Immune-Onc Therapeutics Enters into Licensing Agreement with University of Texas Health Science Center at Houston and University of Texas Southwestern Medical Center 21
arGEN-X Enters into Licensing Agreement with University of Texas Southwestern Medical Center 22
Lonestar Heart Acquires Rights from University of Texas Southwestern Medical 23
arGEN-X Amends its Licensing Agreement with University of Texas Southwestern Medical Center for NHance Technology 24
University Of Illinois And University Of Texas Enter Into Licensing Agreement With StemPar Sciences For Anti-Cancer Compounds 25
LoneStar Heart Enters Into Licensing Agreement With UT Southwestern Medical Center For Isoxazoles 26
University of Texas Southwestern Medical Center, Key Competitors 27
University of Texas Southwestern Medical Center, Key Employees 28
University of Texas Southwestern Medical Center, Other Locations 30
University of Texas Southwestern Medical Center, Subsidiaries 30

★海外企業調査レポート[University of Texas Southwestern Medical Center-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Trovagene Inc (TROV)-医療機器分野:企業M&A・提携分析
    Summary Trovagene Inc (Trovagene) is a development stage molecular diagnostic company focusing on the development and commercialization of proprietary molecular genetic detection technologies for screening and monitoring cancer and other diseases. Its product portfolio includes liquid biopsy tests t …
  • Reliable Ventures India Limited:戦略・SWOT・企業財務分析
    Reliable Ventures India Limited - Strategy, SWOT and Corporate Finance Report Summary Reliable Ventures India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Berner Oberland-Bahnen AG:企業の戦略・SWOT・財務情報
    Berner Oberland-Bahnen AG - Strategy, SWOT and Corporate Finance Report Summary Berner Oberland-Bahnen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • SolarWorld Industries GmbH:企業の戦略的SWOT分析
    SolarWorld Industries GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Biomerica Inc (BMRA):企業の財務・戦略的SWOT分析
    Biomerica Inc (BMRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Invuity Inc (IVTY):企業の財務・戦略的SWOT分析
    Summary Invuity Inc (Invuity) is a medical technology company that develops and markets advanced surgical devices for the minimally invasive and minimal access procedures. The company offers illuminated surgical retractors, single-use handheld aspiration and universal drop-in intracavity illuminator …
  • ERG Renew SpA-エネルギー分野:企業M&A・提携分析
    Summary ERG Renew S.p.A. (ERG Renew), formerly Entad S.p.A., a subsidiary of ERG S.p.A, is a power company that generates electricity from renewable sources. The company generates electricity mainly through wind. ERG Renew and its subsidiaries operate in Italy, France, Bulgaria/Romania, Germany, and …
  • Physical Sciences Inc:製品パイプライン分析
    Summary Physical Sciences Inc (PSI) is a contract research and development service provider that offers basic research and technology development applications. The company provides products such as ISR systems, laser based sensors, passive sensors and RF and optical components. It produces high gain …
  • Fuerst Day Lawson Ltd:企業の戦略・SWOT・財務情報
    Fuerst Day Lawson Ltd - Strategy, SWOT and Corporate Finance Report Summary Fuerst Day Lawson Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Federal Signal Corporation:企業の戦略・SWOT・財務情報
    Federal Signal Corporation - Strategy, SWOT and Corporate Finance Report Summary Federal Signal Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Alkermes Plc (ALKS):企業の財務・戦略的SWOT分析
    Alkermes Plc (ALKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Hibu Group Limited:戦略・SWOT・企業財務分析
    Hibu Group Limited - Strategy, SWOT and Corporate Finance Report Summary Hibu Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Australian Postal Corporation:企業の戦略・SWOT・財務情報
    Australian Postal Corporation - Strategy, SWOT and Corporate Finance Report Summary Australian Postal Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Magellan Health, Inc.:企業の戦略・SWOT・財務情報
    Magellan Health, Inc. - Strategy, SWOT and Corporate Finance Report Summary Magellan Health, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Toronto Hydro Corp:企業の戦略的SWOT分析
    Toronto Hydro Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • United Networks Ltd (UNL):企業の財務・戦略的SWOT分析
    United Networks Ltd (UNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Goldin Properties Holdings Ltd:企業の戦略・SWOT・財務分析
    Goldin Properties Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Goldin Properties Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Integra LifeSciences Holdings Corp (IART):企業の財務・戦略的SWOT分析
    Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Aleris Corporation:企業のM&A・事業提携・投資動向
    Aleris Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aleris Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Caverion Corp:企業の戦略・SWOT・財務情報
    Caverion Corp - Strategy, SWOT and Corporate Finance Report Summary Caverion Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆